Life ScienceCompany
Qiagen N.V M&A Summary
Qiagen N.V has acquired 19 companies of its own, including 5 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 1 asset.
Qiagen N.V’s largest acquisition to date was in 2020, when it acquired NeuMoDx Molecular for $248M. Qiagen N.V has acquired in 7 different US states, and 6 countries. The Company’s most targeted sectors include life science (44%) and medical products (25%).
Qiagen N.V Ownership
Who owns Qiagen N.V?
Qiagen N.V is owned by Thermo Fisher Scientific. It was acquired on March 3, 2020.
Qiagen N.V Business Overview
Where is Qiagen N.V headquartered?
Qiagen N.V is headquartered in Venlo, Netherlands.
What is Qiagen N.V’s revenue?
Qiagen N.V disclosed revenue of 1,526M USD for 2019 and 1,502M USD for 2018.
How many employees does Qiagen N.V have?
Qiagen N.V has 5,200 employees.
What sector is Qiagen N.V in?
Qiagen N.V is a life science company.
When was Qiagen N.V founded?
Qiagen N.V was founded in 1984.
M&A Summary
-
M&A Total Activity17
- M&A Buy Activity16
- M&A Sell Activity1
- Total Sectors Invested 5
- Total Countries Invested 6
- M&A Buy/Sell Connections 10
- M&A Advisors 1
Unlimited Searches
